Arkolith/Insider Trading/HUMA/Form 4

Sander Dale A.

CFO and Chief Corp. Deve. Off.Humacyte, Inc. (HUMA) · full profile →Form 4 · filed Aug 29, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$263K
Net Open-Market Flow
-$263K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 27, 2024Sell(S)39K$6.68$263K2K
Aug 27, 2024Option exercise(M)39K$2.56$101K41K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 27, 2024Option exercise(M)39K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001818382-24-000165) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Humacyte, Inc.

Build

Ask your agent about HUMA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001818382-24-000165"
Ask your agent
Use Arkolith to summarize insider buying and selling at Humacyte, Inc.
over the last 90 days and cite the filings.